Eversept Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.5M Sell
79,229
-16,645
-17% -$8.38M 1.98% 14
2025
Q4
$44.8M Sell
95,874
-15,826
-14% -$7.35M 2.26% 11
2025
Q3
$47.6M Buy
111,700
+11,717
+12% +$4.54M 3.28% 9
2025
Q2
$38.3M Sell
99,983
-52,519
-34% -$18.9M 3.52% 7
2025
Q1
$52.7M Sell
152,502
-23,306
-13% -$7.5M 5.35% 4
2024
Q4
$52.8M Buy
175,808
+46,724
+36% +$16.3M 4.68% 6
2024
Q3
$52.5M Sell
129,084
-6,396
-5% -$2.34M 3.59% 12
2024
Q2
$43.5M Buy
135,480
+31,659
+30% +$10.3M 2.98% 11
2024
Q1
$34.6M Sell
103,821
-10,984
-10% -$3.36M 2.31% 11
2023
Q4
$31.1M Buy
114,805
+4,732
+4% +$1.17M 2.73% 12
2023
Q3
$27.1M Buy
110,073
+29,348
+36% +$8.03M 2.29% 9
2023
Q2
$24.5M Buy
80,725
+52,816
+189% +$14.7M 2.05% 15
2023
Q1
$7.36M Buy
+27,909
New +$7.09M 0.51% 34
2022
Q2
Sell
-111,440
Closed -$27.9M 88
2022
Q1
$27.9M Buy
111,440
+62,346
+127% +$15.7M 2.14% 18
2021
Q4
$12.6M Buy
49,094
+10,728
+28% +$2.63M 0.81% 35
2021
Q3
$9.31M Buy
38,366
+30,052
+361% +$7.35M 0.64% 42
2021
Q2
$1.72M Sell
8,314
-77,095
-90% -$15.7M 0.11% 71
2021
Q1
$16.1M Buy
85,409
+68,655
+410% +$12.1M 1.21% 27
2020
Q4
$2.76M Sell
16,754
-35,646
-68% -$5.21M 0.32% 40
2020
Q3
$6.53M Buy
52,400
+22,000
+72% +$2.72M 1.45% 21
2020
Q2
$2.95M Sell
30,400
-70,600
-70% -$7.34M 0.4% 38
2020
Q1
$9.07M Buy
+101,000
New +$13.1M 2.26% 14

Other funds holding HCA

Eversept Partners's HCA Position: Q1 2026 in Review

Eversept Partners reduced its HCA Healthcare (HCA) stake by 17% in Q1 2026, selling an estimated $8.38M and leaving 79,229 shares worth $37.5M. The position accounts for 1.98% of the portfolio, ranked #14.

Eversept Partners first reported a position in HCA in Q1 2020 and has held it in 22 quarters since. The position peaked at $52.8M in Q4 2024. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Eversept Partners held 79,229 shares of HCA Healthcare worth $37.5M as of Q1 2026.
  • Eversept Partners sold 16,645 HCA Healthcare shares in Q1 2026, an estimated $8.38M.
  • HCA Healthcare made up 1.98% of Eversept Partners's portfolio in Q1 2026, its #14 holding.
  • Eversept Partners first reported a position in HCA Healthcare in Q1 2020 and has held it in 22 quarters since.
  • Eversept Partners's HCA Healthcare position peaked at $52.8M in Q4 2024.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.